Daniel A Morgenstern Advances in Neuroblastoma Research Congress 2016

Daniel A Morgenstern

Consultant and Honorary Senior Lecturer in Paediatric Oncology at Great Ormond Street Hospital and UCL Institute of Child Health, London, UK, with a particular interest in neuroblastoma.

Abstracts this author is presenting:

• Viability Of cryopreserved peripheral blood stem cells (PBSC) does not cuarantee functional activity: important implications for quality assurance of stem cell transplant programmes — Poster Session 1 with wine & cheese
• Primary tumour response to busulfan/melphalan high-dose chemotherapy in patients with high-risk neuroblastoma: a pilot study. — Poster Session 2 with wine & cheese
• Providing information on clinical trials to parents of children with neuroblastoma: a novel liaison in a clinical nurse specialist role. — Poster Session 2 with wine & cheese
• Engraftment following busulfan/melphalan (BuMel) high-dose chemotherapy for high-risk neuroblastoma. A report from the HR-NBL-1/SIOPEN trial. — Poster Session 2 with wine & cheese
• Towards a model for risk stratification of high-risk neuroblastoma. A report from the HR-NBL-1/SIOPEN study. — Parallel 8 Clinical Imaging, Risk Factors and Response